What do BEL512 Phase 2 results mean for Belenos Biosciences and CRSwNP treatment?
Belenos says BEL512 met all Phase 2 CRSwNP endpoints, but undisclosed effect sizes make the planned 2027 Phase 3 trial the critical test.
Pharma & Biotech